A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, ...
A new "tumor-on-a-chip" model is giving scientists a live look at how pancreatic cancer can recruit the body's own immune ...
Researchers found that a rare liver cancer evades immunotherapy by luring immune T cells away from the tumor and trapping ...
Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some ...
Morning Overview on MSN
The FDA cleared donor immune cells to shield blood-cancer patients from deadly complications
Adults with blood cancers who need a stem-cell transplant from a matched donor now have a new option to prevent one of the ...
Researchers at Tel Aviv University’s Gray Faculty of Medical and Health Sciences have identified a mechanism by which cancerous tumors can redirect a normal immune system process to support tumor ...
12don MSN
Nanotech platform combining paclitaxel with siRNA boosts immune response against lung cancer
Researchers at the University of Arizona R. Ken Coit College of Pharmacy have developed a new strategy that helps the immune system recognize and attack lung cancer tumors more effectively. By ...
A research team led by the University of Michigan College of Pharmacy and the University of Texas MD Anderson Cancer Center has developed a new type of nanoparticle therapy that could make cancer ...
Scientists have discovered that creatine may strengthen one of the immune system's most important cancer-fighting pathways by energizing dendritic cells that activate killer T cells. The promising ...
Coupled with TNBC's aggressive biology, high rate of early recurrence, and tendency to metastasize to vital organs like the brain and lungs, long-term outcomes were historically poor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results